Opioids Market by Product (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone and Others) and Application (Pain Management, Cough Treatment, and Diarrhea): Global Opportunity Analysis and Industry Forecast, 2019-2026

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Research Methodology

1.3.1. Secondary Research

1.3.2. Primary Research

1.3.3. Analyst Tools & Models

Chapter 2: Executive Summary

2.1. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope

3.2. Porter'S Five Forces Analysis

3.3. Top Player Positioning

3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increase Use of Opioids In Pain Management

3.4.1.2. Upsurge In Consumption of Opioids In Developing Economies

3.4.2. Restraints

3.4.2.1. Implementation of Stringent Government Regulation Toward Vigorous Prescription

3.4.2.2. Opioid Crisis Across The Globe

3.4.3. Impacting Factors

Chapter 4: Opioids Market, By Product

4.1. Overview

4.1.1. Market Size And Forecast, By Product Type

4.2. Codeine

4.2.1. Key Market Trends

4.2.2. Market Size And Forecast, By Region

4.2.3. Market Analysis, By Country

4.3. Fentanyl

4.3.1. Key Market Trends

4.3.2. Market Size And Forecast, By Region

4.3.3. Market Analysis, By Country

4.4. Oxycodone

4.4.1. Key Market Trends

4.4.2. Market Size And Forecast, By Region

4.4.3. Market Analysis, By Country

4.5. Methadone

4.5.1. Key Market Trends

4.5.2. Market Size And Forecast

4.5.3. Market Analysis, By Country

4.6. Morphine

4.6.1. Key Market Trends

4.6.2. Market Size And Forecast

4.6.3. Market Analysis, By Country

4.7. Hydrocodone

4.7.1. Key Market Trends

4.7.2. Market Size And Forecast

4.7.3. Market Analysis, By Country

4.8. Others

4.8.1. Key Market Trends

4.8.2. Market Size And Forecast

4.8.3. Market Analysis, By Country

Chapter 5: Opioids Market, By Application

5.1. Overview

5.1.1. Market Size And Forecast, By Application

5.2. Pain Management

5.2.1. Market Size And Forecast, By Region

5.2.2. Market Analysis, By Country

5.2.2.1. Neuropathic Pain

5.2.2.1.1. Market Size And Forecast

5.2.2.2. Migraine

5.2.2.2.1. Market Size And Forecast

5.2.2.3. Back Pain

5.2.2.3.1. Market Size And Forecast

5.2.2.4. Osteoarthritis Pain

5.2.2.4.1. Market Size And Forecast

5.2.2.5. Cancer Pain

5.2.2.5.1. Market Size And Forecast

5.2.2.6. Others

5.2.2.6.1. Market Size And Forecast

5.3. Cough Treatment

5.3.1. Market Size And Forecast, By Region

5.3.2. Market Analysis, By Country

5.4. Diarrhea Treatment

5.4.1. Market Size And Forecast, By Region

5.4.2. Market Analysis, By Country

Chapter 6: Opioids Market, By Region

6.1. Overview

6.1.1. Market Size And Forecast

6.2. North America

6.2.1. Key Market Trends

6.2.2. Market Size And Forecast, By Product

6.2.3. Market Size And Forecast, By Application

6.2.4. Market Size And Forecast, By Country

6.2.4.1. U.S. Market Size And Forecast, By Product

6.2.4.2. U.S. Market Size And Forecast, By Application

6.2.4.3. Canada Market Size And Forecast, By Product

6.2.4.4. Canada Market Size And Forecast, By Application

6.2.4.5. Mexico Market Size And Forecast, By Product

6.2.4.6. Mexico Market Size And Forecast, By Application

6.3. Europe

6.3.1. Key Market Trends

6.3.2. Market Size And Forecast, By Product

6.3.3. Market Size And Forecast, By Application

6.3.4. Market Size And Forecast, By Country

6.3.4.1. France Market Size And Forecast, By Product

6.3.4.2. France Market Size And Forecast, By Application

6.3.4.3. Uk Market Size And Forecast, By Product

6.3.4.4. Uk Market Size And Forecast, By Application

6.3.4.5. Germany Market Size And Forecast, By Product

6.3.4.6. Germany Market Size And Forecast, By Application

6.3.4.7. Spain Market Size And Forecast, By Product

6.3.4.8. Spain Market Size And Forecast, By Application

6.3.4.9. Rest of Europe Market Size And Forecast, By Product

6.3.4.10. Rest of Europe Market Size And Forecast, By Application

6.4. Asia-Pacific

6.4.1. Key Market Trends

6.4.2. Market Size And Forecast, By Product

6.4.3. Market Size And Forecast, By Application

6.4.4. Market Size And Forecast, By Country

6.4.4.1. Japan Market Size And Forecast, By Product

6.4.4.2. Japan Market Size And Forecast, By Application

6.4.4.3. China Market Size And Forecast, By Product

6.4.4.4. China Market Size And Forecast, By Application

6.4.4.5. India Market Size And Forecast, By Product

6.4.4.6. India Market Size And Forecast, By Application

6.4.4.7. Australia Market Size And Forecast, By Product

6.4.4.8. Australia Market Size And Forecast, By Application

6.4.4.9. Taiwan Market Size And Forecast, By Product

6.4.4.10. Taiwan Market Size And Forecast, By Application

6.4.4.11. South Korea Market Size And Forecast, By Product

6.4.4.12. South Korea Market Size And Forecast, By Application

6.4.4.13. Rest of Asia-Pacific Market Size And Forecast, By Product

6.4.4.14. Rest of Asia-Pacific Market Size And Forecast, By Application

6.5. Lamea

6.5.1. Key Market Trends

6.5.2. Market Size And Forecast, By Product

6.5.3. Market Size And Forecast, By Application

6.5.4. Market Size And Forecast, By Country

6.5.4.1. Brazil Market Size And Forecast, By Product

6.5.4.2. Brazil Market Size And Forecast, By Application

6.5.4.3. Turkey Market Size And Forecast, By Product

6.5.4.4. Turkey Market Size And Forecast, By Application

6.5.4.5. Saudi Arabia Market Size And Forecast, By Product

6.5.4.6. Saudi Arabia Market Size And Forecast, By Application

6.5.4.7. South Africa Market Size And Forecast, By Product

6.5.4.8. South Africa Market Size And Forecast, By Application

6.5.4.9. Rest of Lamea Market Size And Forecast, By Product

6.5.4.10. Rest of Lamea Market Size And Forecast, By Application

Chapter 7: Compony Profiles

7.1. Allergan Plc.

7.1.1. Company Overview

7.1.2. Company Snapshot

7.1.3. Operating Business Segments

7.1.4. Product Portfolio

7.1.5. Business Performance

7.2. Boehringer Ingelheim Group

7.2.1. Company Overview

7.2.2. Company Snapshot

7.2.3. Operating Business Segments

7.2.4. Product Portfolio

7.2.5. Business Performance

7.3. Endo Pharmaceuticals Inc. (Par Pharmaceutical)

7.3.1. Company Overview

7.3.2. Company Snapshot

7.3.3. Operating Business Segments

7.3.4. Product Portfolio

7.3.5. Business Performance

7.4. Johnson & Johnson (Janssen Global Services, Llc)

7.4.1. Company Overview

7.4.2. Company Snapshot

7.4.3. Operating Business Segments

7.4.4. Product Portfolio

7.4.5. Business Performance

7.5. Mallinckrodt Plc (Specgx Llc)

7.5.1. Company Overview

7.5.2. Company Snapshot

7.5.3. Operating Business Segments

7.5.4. Product Portfolio

7.5.5. Business Performance

7.6. Pfizer Inc.

7.6.1. Company Overview

7.6.2. Company Snapshot

7.6.3. Operating Business Segments

7.6.4. Product Portfolio

7.6.5. Business Performance

7.7. Purdue Pharma L.P.

7.7.1. Company Overview

7.7.2. Company Snapshot

7.7.3. Operating Business Segments

7.7.4. Product Portfolio

7.7.5. Business Performance

7.8. Sanofi S.A.

7.8.1. Company Overview

7.8.2. Company Snapshot

7.8.3. Operating Business Segments

7.8.4. Product Portfolio

7.8.5. Business Performance

7.9. Sun Pharmaceutical Industries Ltd.

7.9.1. Company Overview

7.9.2. Company Snapshot

7.9.3. Operating Business Segments

7.9.4. Product Portfolio

7.9.5. Business Performance

7.10. Teva Pharmaceutical Industries Limited

7.10.1. Company Overview

7.10.2. Company Snapshot

7.10.3. Operating Business Segments

7.10.4. Product Portfolio

7.10.5. Business Performance

Table 01. Global Opioids Market, By Product, 2018–2026 ($Million)

Table 02. Codeine Market, By Region, 2018–2026 ($Million)

Table 03. Codeine Market, By Country, 2018–2026 ($Million)

Table 04. Fentanyl Market By Region 2018–2026 ($Million)

Table 05. Fentanyl Market, By Country, 2018–2026 ($Million)

Table 06. Oxycodone Market, By Region, 2018–2026 ($Million)

Table 07. Oxycodone Market, By Country, 2018–2026 ($Million)

Table 08. Methadone Market, By Region, 2018–2026 ($Million)

Table 09. Methadone Market, By Country, 2018–2026 ($Million)

Table 10. Morphine Market By Region, 2018–2026 ($Million)

Table 11. Morphine Market By Country, 2018–2026 ($Million)

Table 12. Hydrocodone Market, By Region, 2018–2026 ($Million)

Table 13. Hydrocodone Market, By Country, 2018–2026 ($Million)

Table 14. Other Opioid Drugs Market By Region, 2018–2026 ($Million)

Table 15. Other Opioid Drugs Market, By Country, 2018–2026 ($Million)

Table 16. Global Opioids Market, By Application, 2018–2026 ($Million)

Table 17. Opioids Market For Pain Management, By Region, 2018–2026 ($Million)

Table 18. Opioids Market For Cough Treatment, By Region, 2018–2026 ($Million)

Table 19. Opioids Market For Diarrhea Treatment, By Region, 2018–2026 ($Million)

Table 20. Opioids Market, By Region, 2018–2026 ($Million)

Table 21. North America Opioids Market, By Product, 2018–2026 ($Million)

Table 22. North America Opioids Market, By Application, 2018–2026 ($Million)

Table 23. North America Opioids Market, By Country, 2018–2026 ($Million)

Table 24. U.S. Opioids Market, By Product, 2018–2026 ($Million)

Table 25. U.S. Opioids Market, By Application, 2018–2026 ($Million)

Table 26. Canada Opioids Market, By Product, 2018–2026 ($Million)

Table 27. Canada Opioids Market, By Application, 2018–2026 ($Million)

Table 28. Mexico Opioids Market, By Product, 2018–2026 ($Million)

Table 29. Mexico Opioids Market, By Application, 2018–2026 ($Million)

Table 30. Europe Opioids Market, By Product, 2018–2026 ($Million)

Table 31. Europe Opioids Market, By Application, 2018–2026 ($Million)

Table 32. Europe Opioids Market, By Country, 2018–2026 ($Million)

Table 33. France Opioids Market, By Product, 2018–2026 ($Million)

Table 34. France Opioids Market, By Application, 2018–2026 ($Million)

Table 35. Uk Opioids Market, By Product, 2018–2026 ($Million)

Table 36. Uk Opioids Market, By Application, 2018–2026 ($Million)

Table 37. Germany Opioids Market, By Product, 2018–2026 ($Million)

Table 38. Germany Opioids Market, By Application, 2018–2026 ($Million)

Table 39. Spain Opioids Market, By Product, 2018–2026 ($Million)

Table 40. Spain Opioids Market, By Application, 2018–2026 ($Million)

Table 41. Rest of Europe Opioids Market, By Product, 2018–2026 ($Million)

Table 42. Rest of Europe Opioids Market, By Application, 2018–2026 ($Million)

Table 43. Asia-Pacific Opioids Market, By Product, 2018–2026 ($Million)

Table 44. Asia-Pacific Opioids Market, By Application, 2018–2026 ($Million)

Table 45. Asia-Pacific Opioids Market, By Country, 2018–2026 ($Million)

Table 46. Japan Opioids Market, By Product, 2018–2026 ($Million)

Table 47. Japan Opioids Market, By Application, 2018–2026 ($Million)

Table 48. China Opioids Market, By Product, 2018–2026 ($Million)

Table 49. China Opioids Market, By Application, 2018–2026 ($Million)

Table 50. India Opioids Market, By Product, 2018–2026 ($Million)

Table 51. India Opioids Market, By Application, 2018–2026 ($Million)

Table 52. Australia Opioids Market, By Product, 2018–2026 ($Million)

Table 53. Australia Opioids Market, By Application, 2018–2026 ($Million)

Table 54. Taiwan Opioids Market, By Product, 2018–2026 ($Million)

Table 55. Taiwan Opioids Market, By Application, 2018–2026 ($Million)

Table 56. South Korea Opioids Market, By Product, 2018–2026 ($Million)

Table 57. South Korea Opioids Market, By Application, 2018–2026 ($Million)

Table 58. Rest of Asia-Pacific Opioids Market, By Product, 2018–2026 ($Million)

Table 59. Rest of Asia-Pacific Opioids Market, By Application, 2018–2026 ($Million)

Table 60. Lamea Opioids Market, By Product, 2018–2026 ($Million)

Table 61. Lamea Opioids Market, By Application, 2018–2026 ($Million)

Table 62. Lamea Opioids Market, By Country, 2018–2026 ($Million)

Table 63. Brazil Opioids Market, By Product, 2018–2026 ($Million)

Table 64. Brazil Opioids Market, By Application, 2018–2026 ($Million)

Table 65. Turkey Opioids Market, By Product, 2018–2026 ($Million)

Table 66. Turkey Opioids Market, By Application, 2018–2026 ($Million)

Table 67. Saudi Arabia Opioids Market, By Product, 2018–2026 ($Million)

Table 68. Saudi Arabia Opioids Market, By Application, 2018–2026 ($Million)

Table 69. South Africa Opioids Market, By Product, 2018–2026 ($Million)

Table 70. South Africa Opioids Market, By Application, 2018–2026 ($Million)

Table 71. Rest of Lamea Opioids Market, By Product, 2018–2026 ($Million)

Table 72. Rest of Lamea Opioids Market, By Application, 2018–2026 ($Million)

Table 73. Allergan: Company Snapshot

Table 74. Allergan: Operating Segments

Table 75. Allergan: Product Portfolio

Table 76. Boehringer Ingelheim: Company Snapshot

Table 77. Boehringer Ingelheim: Operating Segments

Table 78. Boehringer Ingelheim: Product Portfolio

Table 79. Endo: Company Snapshot

Table 80. Endo: Operating Segments

Table 81. Endo: Product Portfolio

Table 82. J&J: Company Snapshot

Table 83. J&J: Operating Segments

Table 84. J&J: Product Type Portfolio

Table 85. Mallinckrodt: Company Snapshot

Table 86. Mallinckrodt: Operating Segments

Table 87. Mallinckrodt: Product Portfolio

Table 88. Pfizer: Company Snapshot

Table 89. Pfizer: Operating Segments

Table 90. Pfizer: Product Portfolio

Table 91. Purdue: Company Snapshot

Table 92. Purdue: Product Portfolio

Table 93. Sanofi: Company Snapshot

Table 94. Sanofi: Operating Segments

Table 95. Sanofi: Product Portfolio

Table 96. Sun Pharma: Company Snapshot

Table 97. Sun Pharma: Operating Segments

Table 98. Sun Pharma: Product Portfolio

Table 99. Teva: Company Snapshot

Table 100. Teva: Operating Segments

Table 101. Teva: Product Portfolio